principles of antimicrobial therapy · title: drugs for dermatological disorders author: tareq...
TRANSCRIPT
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Principles of Antimicrobial Therapy
Pharmacology and Toxicology
General Pharmacology
Second Year Medical Students
Tareq Saleh
Faculty of Medicine
The Hashemite University
Textbook reference: 355-367
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
How Did Antibiotics Change The World?
• Life expectancy: 47 yearsto 78 years (Westerncountries)
• Major cause of death:communicable diseases tonon-communicablediseases
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Overview
Selective Toxicity:
“The ability of an agent to injureor kill an invading microorganismwithout harming host cells”
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Selection of Antimicrobial Agent
What needs to be known?
• The organism’s identity
• The organism’s susceptibility to a particular agent
• The site of the infection
• Patient factors
• The safety of the agent
• The cost of therapy
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Identification of The Infecting Organism
• Gram stain:• presence of microorganisms in sterile
body fluids.
• morphologic features
• Culture:• diagnosis
• antibiotic susceptibility
• Microbial antigens• DNA, RNA, etc
• Host immune markers
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Empiric Therapy prior to Identification of The Organism
• Greek empeiria = experience.
❑Timing
- Immediate treatment: e.g.,critically-ill, neutropenic,meningitis.
❑Selecting a drug
- Site of infection
- Clinical picture
- Broad-spectrum therapy
Example:
A 40-year-old patient withgram- positive cocci in thespinal fluid. These are mostlikely be S. pneumoniae. S.pneumoniae is frequentlyresistant to penicillin G.Empirically treat with ahigh-dose third-generationcephalosporin (such asceftriaxone) or vancomycin.
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Determining Antimicrobial Susceptibility of Infective Organisms
• Predictable vs unpredictable susceptibility
• The susceptibility of a microorganism to a drugcan be experimentally determined
MIC MBC
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Determination of minimum inhibitory concentration (MIC) andminimum bactericidal concentration (MBC) of an antibiotic.
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Determination of minimum inhibitory concentration (MIC) andminimum bactericidal concentration (MBC) of an antibiotic.
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Determination of minimum inhibitory concentration (MIC) andminimum bactericidal concentration (MBC) of an antibiotic.
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Practice Question
• You have 5 tubes and want to do 5 dilutions of antibiotic X on thegrowth of E.coli. Tubes 1-2 do not have growth, but tubes 3-5 havegrowth, the tube with the MIC would be?
#1 #2 #3 #4 #5
Low
est
Do
se
Hig
hes
t D
ose
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Practice Question
• Subcultures of the last 5 tubes gave the following results. Which tubehas MBC?
#1 #2 #3 #4 #5
Low
est
Do
se
Hig
hes
t D
ose
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Example
Tested bacteria: E.coli
Which antibiotic E.coli is more susceptible to?
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Bacteriostatic vs Bactericidal
❑Bacteriostatic: arrest thegrowth/replication of amicroorganism
❑Bactericidal: kill bacteria(kill ≥ 99.9%)
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Bacteriostatic vs Bactericidal
But…
❑Classification is too simplistic
❑Microorganism-dependent
❑Similar efficacy for clinical infections
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Effect of The Site of Infection on Therapy: The Blood–Brain Barrier
1. Lipid solubility of the drug:
-Lipid-soluble drugs e.g., chloramphenicol and metronidazole
-low-lipid-soluble drugs: e.g., penicillin
-meningitis
2. Molecular weight of the drug:
-low molecular weight more ability to cross the BBB
3. Protein binding of the drug:
-amount of free (unbound) drug not the total amount of drug
4. …….
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Patient Factors
1. Immune system:
- host defense system must ultimately eliminate the invadingorganisms.
- factors influencing immunocompetence: alcoholism, diabetes, HIVinfection, malnutrition, autoimmune diseases, pregnancy, advancedage, immunosuppressive drugs.
2. Renal dysfunction
3. Hepatic dysfunction
4. Poor perfusion
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Patient Factors
5. Age
6. Pregnancy
7. Risk factors for multidrug-resistantorganisms:
- prior antimicrobial therapy in the preceding90 days
- hospitalization for greater than 2 days withinthe preceding 90 days
- current hospitalization exceeding 5 days
- high frequency of resistance in thecommunity or local hospital unit (assessedusing hospital antibiograms)
- immunosuppressive diseases and/ortherapies
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Cost of Therapy: Is It Important?
Relative cost of some drugs used for the treatment of Staphylococcus aureus.
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Determinants Of Rational Dosing
A. Concentration-dependent killing
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Determinants Of Rational Dosing
B. Time-dependent (concentration-independent) killing
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Determinants Of Rational Dosing
C. Postantibioticeffect = persistentsuppression ofmicrobial growththat occurs afterlevels of antibiotichave fallen belowthe MIC
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Chemotherapeutic Spectra
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Chemotherapeutic Spectra
• Narrow-spectrum antibiotics:
Chemotherapeutic agents actingonly on a single or a limited groupof microorganisms.
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Chemotherapeutic Spectra
• Extended-spectrum antibiotics:
antibiotics that are modified to beeffective against gram-positiveorganisms and also against asignificant number of gram-negative bacteria
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Chemotherapeutic Spectra
• Broad-spectrum antibiotics:
antibiotic that acts on both gram-positive and gram-negativebacteria
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Combinations of Antimicrobial Agents
A. Advantages of drug combinations:
- synergism: combination is moreeffective than either of the drugs usedseparately.
- Unknown origin/empirical
- Organisms with variable sensitivity
B. Disadvantages of drug combinations:
- Interference in the mode of action:bacteriostatic + bactericidal
- selection pressure/antimicrobialresistance
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Prophylactic Use Of Antibiotics“Prevention not treatment”
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Complications Of Antibiotic Therapy
A. Hypersensitivity
-ranges from mild skin rash to life-threatening anaphylaxis
UrticariaDrug: penicillin
Red man syndromeDrug: vancomycin
Steven-Johnson syndromeDrug: penicillins, sulfa drugs
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Complications Of Antibiotic Therapy
B. Direct Toxicity
C. Superinfections:
- mainly with broad-spectrum agents
- Overgrowth of opportunistic organisms
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Question
• Which of the following adverse drug reactions precludes a patient from being rechallenged with that drug in the future?
A. Skin rash-Penicillin
B. Toxic epidermal necrolysis – sulfamethoxazole/trimethoprim
C. GI upset - clarithromycin
D. Pseudomembranous colitis – clindamycin
E. Kidney injury - gentamicin
-
Copyright © 2018 Wolters Kluwer • All Rights ReservedTareq Saleh ©
Sites Of Antimicrobial Actions